← Eichor
Study identifier: NCT07144319 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

Condition: Bladder Cancer · Non-muscle Invasive Bladder Cancer  ·  Sponsor: Photocure

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Blue light cystoscopy (BLC) is a diagnostic procedure in bladder cancer where the inside of the bladder is observed with a camera to detect bladder lesions. Unlike regular white light cystoscopy, blue light cystoscopy makes use of a drug that induces fluorescence under blue light preferentially in neoplastic and malignant cells that helps visualize bladder lesions during the cystoscopic procedure. Blue light cystoscopy has shown to improve detection of bladder cancer. Cystoscopy, including blue light cystoscopy, is a procedure involving assessment of the visual appearance of the bladder surface, leading to decisions of taking biopsies, remove suspicious areas and assign treatment options. The assessment is subjective and has a large operator variability. These shortcomings show an opportunity for computer aided detection (CADe) medical device to add value to both clinicians and patients. The objective of this data collection study is to build a high-quality, diverse data set of video, image recordings and relevant clinical data from BLC procedures performed as part of routine clinical practice to train a computer-aided detection (CADe) algorithm for real- time lesion detection during cystoscopy. The data will be used to support the training, non-clinical technical development and testing of such AI algorithms for use during cystoscopy and to provide documentation needed for training of such algorithms and to assist in guiding future validation of such algorithms. Explorato…

This description comes directly from the study's public registry record.

Talk to the study team

Kristine Young-Halvorsen, PhD  ·  004722062210  ·  research@photocure.com

Always discuss trial participation with your own doctor first.

Locations (4)

Moffitt Cancer CenterTampa, Florida, United StatesRecruiting
Regents of the University of MichiganAnn Arbor, Michigan, United StatesRecruiting
Rutgers Cancer InstituteNew Brunswick, New Jersey, United StatesRecruiting
Oslo University HospitalOslo, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07144319